Antithrombotic potencies of enoxaparin in microvascular surgery: Influence of dose and administration methods on patency rate of crushed arterial anastomoses

Journal of Hand Surgery

Volumn 22, Issue 3, 1997, Pages 540-546

  Korompilias, A V ^a   Chen, L E ^a   Seaber, A V ^a   Urbaniak, J R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRUSH TRAUMA; DRUG EFFECT; DRUG EFFICACY; FEMORAL ARTERY; HUMAN; PRIORITY JOURNAL; RAT; THROMBOSIS; TOPICAL DRUG ADMINISTRATION;

EID: 0030922283     PISSN: 03635023     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0363-5023(97)80026-3     Document Type: Article

References (43)

1. Urbaniak JR Replantation Green DP Operative hand surgery 3rd ed. 1993 Churchill Livingstone New York 1085 1102
2. Tamai T Twenty years' experience of limb replantation: a review of 293 upper extremity replants J Hand Surg 6 1982 549 556
3. Wieslander JB Dougan P Stjernquist U Mecklenburg CV Effect of dextran 70 and saline in thrombus formation following arteriotomy and intimectomy in small arteries Microsurgery 7 1986 168 177
4. Cooley BC Jones MM Dellon AL Comparison of efficacy of thrombolysin, streptokinase, and urokinase in a femoral vein clot model in rats Microsurgery 4 1983 1 4
5. Zhang B Wieslander JB Improvement of patency in small veins following dextran and/or low molecular weight heparin treatment Plast Reconstr Surg 94 1994 352 358
6. Buckley RC Davidson SF Das SK The role of various antithrombotic agents in microvascular surgery Br J Plast Surg 47 1994 20 23
7. Kronen G Ferder M Hunzicker K Strauch B The use of pentoxifylline in microvascular surgery J Reconstr Microsurg 10 1994 17 20
8. Das SK Miller JH Current status of topical antithrombotic agents in microvascular surgery Microsurgery 15 1994 630 633
9. Cooley BC Gould JS Topically applied antithrombotic agents offer a new therapeutic approach to the prevention of microvascular thrombosis Microsurgery 12 1991 281 287
10. Siegel DB Use of anticoagulants in replantation and elective microsurgery Microsurgery 12 1991 277 280
11. Khouri RK Cooley BC Kenna DM Edstrom LE Thrombosis of microvascular anastomoses in traumatized vessels: fibrin versus platelets Plast Reconstr Surg 86 1990 110 117
12. Kersh RA Handren J Hergrueter C May JW Microvascular surgical experimental thrombosis model: rationale and design Plast Reconstr Surg 83 1988 866 872
13. Cooley BC Gould JS Experimental models for evaluating antithrombotic therapies in replantation microsurgery Microsurgery 8 1987 230 233
14. Greenberg BM Masem M Wang YX Rubin P May JR Efficacy of intraterial heparin in maintaining microvascular patency: an experimental model Plast Reconstr Surg 87 1991 933 940
15. Davidson SF Brantley SK Talbot PJ Das SK A functional model of microvascular thrombosis Plast Reconstr Surg 86 1990 579 581
16. Chen LE Seaber AV Urbaniak JR Thrombosis and thrombolysis in crushed arteries with or without anastomosis: a new microvascular thrombosis model J Reconstr Microsurg 12 1996 31 38
17. Sinclair S The importance of topical heparin in microvascular anastomoses: a study in the rat Br J Plast Surg 33 1990 422 426
18. Wieslander JB Dougan P Washout of vessels with heparin does not improve patency following severe microarterial trauma: an experimental study Ann Plast Surg 24 1990 216 222
19. Cox GW Runnels S Hsu HSH Das SK A comparison of heparinized saline irrigation solutions in a model of microvascular thrombosis Br J Plast Surg 45 1992 345 347
20. Li X Cooley BC Gould JS Influence of topical heparin on statis-induced thrombosis of microvascular anastomoses Microsurgery 13 1992 72 75
21. Eriksson BI Kalebo P Anthmyr B Wadenvik H Tengborn L Risberg B Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement: comparison of low-molecular-weight heparin and unfractioned heparin J Bone Joint Surg 73A 1991 484 493
22. Salemark L International survey of current microvascular practices in free tissue transfer and replantation surgery Microsurgery 12 1991 308 311
23. Mammen EF Why low molecular weight heparin? Semin Thromb Hemost 16 suppl 1990 1 4
24. Kakkar VV Djazaeri B Fok J Fletcher M Scully MF Westwick J Low-molecular-weight heparin and prevention of postoperative deep vein thrombosis BMJ 284 1982 375 382
25. Harris WH Salzman EW Athanasoulis C Waltman AC Baum S DeSanctis RW Comparison of warfarin, low-molecular-weight dextran aspirin, and subcutaneous heparin in prevention of venous thromboebolism following total hip replacement J Bone Joint Surg 56A 1974 1552 1562
26. Chen LE Seaber AV Korompilias AV Urbaniak JR Effects of topical administration of lovenox, standard heparin, and streptokinase on the patency of anastomosis in crushed arteries Microsurgery 16 1995 661 665
27. Chen LE Seaber AV Glisson RR Mikat EM Urbaniak JR Morphologic and morphometric analyses of rat femoral arteries after crush injury Microsurgery 12 1991 402 411
28. Goodfellow BS Mikat EM A stain for the simultaneous demonstration of collagen, muscle, an elastic elements in mammalian tissue Lab Med 19 1988 243 244
29. Messmore HL Wehrmacher WH Therapeutic use of low-molecular-weight-heparins Semin Thromb Haemost 19 suppl 1 1993 97 100
30. Fareed J Heparin, its fractions, fragments and derivatives: some newer perspectives Semin Thromb Haemost 11 suppl 1 1985 1 9
31. Fareed J Hoppensteadt DA Walenga JM Current prospectives on low molecular weight heparins Semin Thromb Hemost 19 suppl 1 1993 1 11
32. Fareed J Walenga JM Lassen M Borris L Hoppensateadt D Pharmacologic profile of a low molecular weight heparin (enoxaparin): experimental and clinical validation of the prophylactic antithrombotic effects Acta Chir Scand 156 suppl 556 1990 75 90
33. Haas S Haas P Efficacy of low molecular weight heparins: an overview Semin Thromb Hemost 19 suppl 1 1993 1 9
34. Cowell CW Spiro TE Trowbridge AA Use of enoxaparin, a low-molecular-weight heparin, and unfractioned heparin for the prevention of deep venous thrombosis after elective hip replacement J Bone Joint Surg 76A 1994 3 14
35. Turpie AG Levine MN Hirsh J A randomized controlled trial of a low-molecular-weight-heparin (enoxaparin) to prevent deep-vein thrombosis in patients under-going elective hip surgery N Engl J Med 315 1986 925 929
36. Savoie FH Cooley BC Gould JS Evaluation of the effect of pharmacological agents on crush-avulsion arterial injuries: a scanning electron microscopy study Microsurgery 12 1991 292 300
37. Borstad E Urdal K Handeland G Abildgaard U Comparison of low molecular weight heparin vs. unfractioned heparin in gynecological surgery Acta Obstet Gynecol Scand 67 1988 99 103
38. Borstad E Urdal K Handeland G Abildgaard U Comparison of low molecular weight heparin vs. unfractioned heparin in gynecological surgery II: reduced dose of low molecular weight heparin Acta Obstet Gynecol Scand 71 1993 471 475
39. Hull RD Pineo GF Theurapeutic use of low molecular weight heparins; the knowledge to date as applied to therapy Semin Thromb Hemost 19 suppl 1 1993 111 115
40. Levine MN Hirsch J Gent M Prevention of deep vein thrombosis after elective hip surgery: a randomized trial comparing low molecular weight heparin with standard unfractionated heparin Ann Inter Med 114 1991 545 551
41. Fejgin MD Lourwood DL Low molecular weight heparins and their use in obstetrics and gynecology Obstet Gynecol Surv 49 1994 424 431
42. Isogai N Kamiishi H Chichibu S Re-endothelialization stages at the microvascular anastomosis Microsurgery 9 1988 87 92
43. Zhang B Wieslander JB Healing of a severe microarterial trauma Microsurgery 15 1994 130 140